ResearcherSun Yat-sen UniversityActive in the last 2 years

Zixi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-8845-2904; OpenAlex author ID A5075617938. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic Abilities of Erlotinib in Pancreatic Can… Last author DOI 10.2174/0115680096423484251129063926 ↗
Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jconrel.2025.113588 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sarwar Ammar · 1 shared paper, 2026 · strength 0.27
- Paper Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic … DOI 10.2174/0115680096423484251129063926 ↗
Yanmin Zhang · 1 shared paper, 2026 · strength 0.27
- Paper Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic … DOI 10.2174/0115680096423484251129063926 ↗
Jinjin Chen · 1 shared paper, 2025 · strength 0.22
- Paper Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic … DOI 10.1016/j.jconrel.2025.113588 ↗
Qian Shen · 1 shared paper, 2025 · strength 0.22
- Paper Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic … DOI 10.1016/j.jconrel.2025.113588 ↗
Xiaoding Xu · 1 shared paper, 2025 · strength 0.22
- Paper Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic … DOI 10.1016/j.jconrel.2025.113588 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.